Evidence map›Paper›PMID 41531735›Full record

ArticleiScience2026

Andrographolide inhibits the upregulation of SLC19A3 to block the adipogenic differentiation of adipose-derived stem cells.

Yili Yang, Xuan Wang, Guangfeng Zhou, Xiaodan Hou, Yang He, Yuan Feng, Yuxue Jiang, Yuexi Gu, Jun Ye

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yili YangChina Regional Research Centre, International Centre for Genetic Engineering and Biotechnology (ICGEB), Taizhou, Jiangsu 225316, P.R. China.
Xuan WangChina Regional Research Centre, International Centre for Genetic Engineering and Biotechnology (ICGEB), Taizhou, Jiangsu 225316, P.R. China.
Guangfeng ZhouCenter for Public Health Research, School of Medicine, Nanjing University, Nanjing, Jiangsu 211166, P.R. China.
Xiaodan HouSuzhou Kintor Pharmaceuticals, Suzhou, Jiangsu 215127, P.R. China.
Yang HeHelixon Biotechnology, Suzhou, Jiangsu 215128, P.R. China.
Yuan FengSuzhou Institute of Systems Medicine, Center for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, Jiangsu 215004, P.R. China.
Yuxue JiangCentral Laboratory, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, Jiangsu 225300, P.R. China.
Yuexi GuChina Regional Research Centre, International Centre for Genetic Engineering and Biotechnology (ICGEB), Taizhou, Jiangsu 225316, P.R. China.
Jun YeCentral Laboratory, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, Jiangsu 225300, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We found that andrographolide (AP), the main active component of medicinal herb

Indexed as

Biological sciencesCell biologyHealth sciencesNatural product biochemistryNatural sciences

Identifiers

PMID41531735
PMCPMC12794426

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.